Global COVID-19 Vaccine Development Tools Market Research Report 2023

COVID-19 Vaccine Development Tools Market

The global COVID-19 Vaccine Development Tools market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

North American market for COVID-19 Vaccine Development Tools is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

Asia-Pacific market for COVID-19 Vaccine Development Tools is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The global market for COVID-19 Vaccine Development Tools in Pharmaceutical Company is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The key global companies of COVID-19 Vaccine Development Tools include Thermo Fisher Scientific, Pfizer Inc, Celerion, Cole-Parmer Instrument Company, STEMCELL Technologies, Illumina, Inc, AB Sciex Private Limited, Agilent Technologies and Danaher Corporation, etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for COVID-19 Vaccine Development Tools, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding COVID-19 Vaccine Development Tools.

The COVID-19 Vaccine Development Tools market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global COVID-19 Vaccine Development Tools market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the COVID-19 Vaccine Development Tools companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.

Scope of COVID-19 Vaccine Development Tools Market Report

Core Chapters

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global COVID-19 Vaccine Development Tools Market Size Growth Rate by Type: 2018 VS 2022 VS 2029

1.2.2 Flow Cytometry

1.2.3 Electron Microscopy

1.2.4 Spectrometry

1.2.5 Others

1.3 Market by Application

1.3.1 Global COVID-19 Vaccine Development Tools Market Growth by Application: 2018 VS 2022 VS 2029

1.3.2 Pharmaceutical Company

1.3.3 Biotechnology Company

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2.1 Global COVID-19 Vaccine Development Tools Market Perspective (2018-2029)

2.2 COVID-19 Vaccine Development Tools Growth Trends by Region

2.2.1 Global COVID-19 Vaccine Development Tools Market Size by Region: 2018 VS 2022 VS 2029

2.2.2 COVID-19 Vaccine Development Tools Historic Market Size by Region (2018-2023)

2.2.3 COVID-19 Vaccine Development Tools Forecasted Market Size by Region (2024-2029)

2.3 COVID-19 Vaccine Development Tools Market Dynamics

2.3.1 COVID-19 Vaccine Development Tools Industry Trends

2.3.2 COVID-19 Vaccine Development Tools Market Drivers

2.3.3 COVID-19 Vaccine Development Tools Market Challenges

2.3.4 COVID-19 Vaccine Development Tools Market Restraints

3.1 Global Top COVID-19 Vaccine Development Tools Players by Revenue

3.1.1 Global Top COVID-19 Vaccine Development Tools Players by Revenue (2018-2023)

3.1.2 Global COVID-19 Vaccine Development Tools Revenue Market Share by Players (2018-2023)

3.2 Global COVID-19 Vaccine Development Tools Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by COVID-19 Vaccine Development Tools Revenue

3.4 Global COVID-19 Vaccine Development Tools Market Concentration Ratio

3.4.1 Global COVID-19 Vaccine Development Tools Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by COVID-19 Vaccine Development Tools Revenue in 2022

3.5 COVID-19 Vaccine Development Tools Key Players Head office and Area Served

3.6 Key Players COVID-19 Vaccine Development Tools Product Solution and Service

3.7 Date of Enter into COVID-19 Vaccine Development Tools Market

3.8 Mergers & Acquisitions, Expansion Plans

4.1 Global COVID-19 Vaccine Development Tools Historic Market Size by Type (2018-2023)

4.2 Global COVID-19 Vaccine Development Tools Forecasted Market Size by Type (2024-2029)

5.1 Global COVID-19 Vaccine Development Tools Historic Market Size by Application (2018-2023)

5.2 Global COVID-19 Vaccine Development Tools Forecasted Market Size by Application (2024-2029)

6.1 North America COVID-19 Vaccine Development Tools Market Size (2018-2029)

6.2 North America COVID-19 Vaccine Development Tools Market Growth Rate by Country: 2018 VS 2022 VS 2029

6.3 North America COVID-19 Vaccine Development Tools Market Size by Country (2018-2023)

6.4 North America COVID-19 Vaccine Development Tools Market Size by Country (2024-2029)

6.5 United States

6.6 Canada

7.1 Europe COVID-19 Vaccine Development Tools Market Size (2018-2029)

7.2 Europe COVID-19 Vaccine Development Tools Market Growth Rate by Country: 2018 VS 2022 VS 2029

7.3 Europe COVID-19 Vaccine Development Tools Market Size by Country (2018-2023)

7.4 Europe COVID-19 Vaccine Development Tools Market Size by Country (2024-2029)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8.1 Asia-Pacific COVID-19 Vaccine Development Tools Market Size (2018-2029)

8.2 Asia-Pacific COVID-19 Vaccine Development Tools Market Growth Rate by Region: 2018 VS 2022 VS 2029

8.3 Asia-Pacific COVID-19 Vaccine Development Tools Market Size by Region (2018-2023)

8.4 Asia-Pacific COVID-19 Vaccine Development Tools Market Size by Region (2024-2029)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9.1 Latin America COVID-19 Vaccine Development Tools Market Size (2018-2029)

9.2 Latin America COVID-19 Vaccine Development Tools Market Growth Rate by Country: 2018 VS 2022 VS 2029

9.3 Latin America COVID-19 Vaccine Development Tools Market Size by Country (2018-2023)

9.4 Latin America COVID-19 Vaccine Development Tools Market Size by Country (2024-2029)

9.5 Mexico

9.6 Brazil

10.1 Middle East & Africa COVID-19 Vaccine Development Tools Market Size (2018-2029)

10.2 Middle East & Africa COVID-19 Vaccine Development Tools Market Growth Rate by Country: 2018 VS 2022 VS 2029

10.3 Middle East & Africa COVID-19 Vaccine Development Tools Market Size by Country (2018-2023)

10.4 Middle East & Africa COVID-19 Vaccine Development Tools Market Size by Country (2024-2029)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11.1 Thermo Fisher Scientific

11.1.1 Thermo Fisher Scientific Company Detail

11.1.2 Thermo Fisher Scientific Business Overview

11.1.3 Thermo Fisher Scientific COVID-19 Vaccine Development Tools Introduction

11.1.4 Thermo Fisher Scientific Revenue in COVID-19 Vaccine Development Tools Business (2018-2023)

11.1.5 Thermo Fisher Scientific Recent Development

11.2 Pfizer Inc

11.2.1 Pfizer Inc Company Detail

11.2.2 Pfizer Inc Business Overview

11.2.3 Pfizer Inc COVID-19 Vaccine Development Tools Introduction

11.2.4 Pfizer Inc Revenue in COVID-19 Vaccine Development Tools Business (2018-2023)

11.2.5 Pfizer Inc Recent Development

11.3 Celerion

11.3.1 Celerion Company Detail

11.3.2 Celerion Business Overview

11.3.3 Celerion COVID-19 Vaccine Development Tools Introduction

11.3.4 Celerion Revenue in COVID-19 Vaccine Development Tools Business (2018-2023)

11.3.5 Celerion Recent Development

11.4 Cole-Parmer Instrument Company

11.4.1 Cole-Parmer Instrument Company Company Detail

11.4.2 Cole-Parmer Instrument Company Business Overview

11.4.3 Cole-Parmer Instrument Company COVID-19 Vaccine Development Tools Introduction

11.4.4 Cole-Parmer Instrument Company Revenue in COVID-19 Vaccine Development Tools Business (2018-2023)

11.4.5 Cole-Parmer Instrument Company Recent Development

11.5 STEMCELL Technologies

11.5.1 STEMCELL Technologies Company Detail

11.5.2 STEMCELL Technologies Business Overview

11.5.3 STEMCELL Technologies COVID-19 Vaccine Development Tools Introduction

11.5.4 STEMCELL Technologies Revenue in COVID-19 Vaccine Development Tools Business (2018-2023)

11.5.5 STEMCELL Technologies Recent Development

11.6 Illumina, Inc

11.6.1 Illumina, Inc Company Detail

11.6.2 Illumina, Inc Business Overview

11.6.3 Illumina, Inc COVID-19 Vaccine Development Tools Introduction

11.6.4 Illumina, Inc Revenue in COVID-19 Vaccine Development Tools Business (2018-2023)

11.6.5 Illumina, Inc Recent Development

11.7 AB Sciex Private Limited

11.7.1 AB Sciex Private Limited Company Detail

11.7.2 AB Sciex Private Limited Business Overview

11.7.3 AB Sciex Private Limited COVID-19 Vaccine Development Tools Introduction

11.7.4 AB Sciex Private Limited Revenue in COVID-19 Vaccine Development Tools Business (2018-2023)

11.7.5 AB Sciex Private Limited Recent Development

11.8 Agilent Technologies

11.8.1 Agilent Technologies Company Detail

11.8.2 Agilent Technologies Business Overview

11.8.3 Agilent Technologies COVID-19 Vaccine Development Tools Introduction

11.8.4 Agilent Technologies Revenue in COVID-19 Vaccine Development Tools Business (2018-2023)

11.8.5 Agilent Technologies Recent Development

11.9 Danaher Corporation

11.9.1 Danaher Corporation Company Detail

11.9.2 Danaher Corporation Business Overview

11.9.3 Danaher Corporation COVID-19 Vaccine Development Tools Introduction

11.9.4 Danaher Corporation Revenue in COVID-19 Vaccine Development Tools Business (2018-2023)

11.9.5 Danaher Corporation Recent Development

11.10 Bio-Rad Laboratories

11.10.1 Bio-Rad Laboratories Company Detail

11.10.2 Bio-Rad Laboratories Business Overview

11.10.3 Bio-Rad Laboratories COVID-19 Vaccine Development Tools Introduction

11.10.4 Bio-Rad Laboratories Revenue in COVID-19 Vaccine Development Tools Business (2018-2023)

11.10.5 Bio-Rad Laboratories Recent Development

11.11 Qiagen NV

11.11.1 Qiagen NV Company Detail

11.11.2 Qiagen NV Business Overview

11.11.3 Qiagen NV COVID-19 Vaccine Development Tools Introduction

11.11.4 Qiagen NV Revenue in COVID-19 Vaccine Development Tools Business (2018-2023)

11.11.5 Qiagen NV Recent Development

11.12 Merck KgaA

11.12.1 Merck KgaA Company Detail

11.12.2 Merck KgaA Business Overview

11.12.3 Merck KgaA COVID-19 Vaccine Development Tools Introduction

11.12.4 Merck KgaA Revenue in COVID-19 Vaccine Development Tools Business (2018-2023)

11.12.5 Merck KgaA Recent Development

11.13 Shimadzu Corporation

11.13.1 Shimadzu Corporation Company Detail

11.13.2 Shimadzu Corporation Business Overview

11.13.3 Shimadzu Corporation COVID-19 Vaccine Development Tools Introduction

11.13.4 Shimadzu Corporation Revenue in COVID-19 Vaccine Development Tools Business (2018-2023)

11.13.5 Shimadzu Corporation Recent Development

11.14 PerkinElmer Inc

11.14.1 PerkinElmer Inc Company Detail

11.14.2 PerkinElmer Inc Business Overview

11.14.3 PerkinElmer Inc COVID-19 Vaccine Development Tools Introduction

11.14.4 PerkinElmer Inc Revenue in COVID-19 Vaccine Development Tools Business (2018-2023)

11.14.5 PerkinElmer Inc Recent Development

11.15 Eurofins Scientific

11.15.1 Eurofins Scientific Company Detail

11.15.2 Eurofins Scientific Business Overview

11.15.3 Eurofins Scientific COVID-19 Vaccine Development Tools Introduction

11.15.4 Eurofins Scientific Revenue in COVID-19 Vaccine Development Tools Business (2018-2023)

11.15.5 Eurofins Scientific Recent Development

11.16 Aurora Biomed

11.16.1 Aurora Biomed Company Detail

11.16.2 Aurora Biomed Business Overview

11.16.3 Aurora Biomed COVID-19 Vaccine Development Tools Introduction

11.16.4 Aurora Biomed Revenue in COVID-19 Vaccine Development Tools Business (2018-2023)

11.16.5 Aurora Biomed Recent Development

11.17 Sartorius AG

11.17.1 Sartorius AG Company Detail

11.17.2 Sartorius AG Business Overview

11.17.3 Sartorius AG COVID-19 Vaccine Development Tools Introduction

11.17.4 Sartorius AG Revenue in COVID-19 Vaccine Development Tools Business (2018-2023)

11.17.5 Sartorius AG Recent Development

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

List of Tables

    Table 1. Global COVID-19 Vaccine Development Tools Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029

    Table 2. Key Players of Flow Cytometry

    Table 3. Key Players of Electron Microscopy

    Table 4. Key Players of Spectrometry

    Table 5. Key Players of Others

    Table 6. Global COVID-19 Vaccine Development Tools Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029

    Table 7. Global COVID-19 Vaccine Development Tools Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 8. Global COVID-19 Vaccine Development Tools Market Size by Region (2018-2023) & (US$ Million)

    Table 9. Global COVID-19 Vaccine Development Tools Market Share by Region (2018-2023)

    Table 10. Global COVID-19 Vaccine Development Tools Forecasted Market Size by Region (2024-2029) & (US$ Million)

    Table 11. Global COVID-19 Vaccine Development Tools Market Share by Region (2024-2029)

    Table 12. COVID-19 Vaccine Development Tools Market Trends

    Table 13. COVID-19 Vaccine Development Tools Market Drivers

    Table 14. COVID-19 Vaccine Development Tools Market Challenges

    Table 15. COVID-19 Vaccine Development Tools Market Restraints

    Table 16. Global COVID-19 Vaccine Development Tools Revenue by Players (2018-2023) & (US$ Million)

    Table 17. Global COVID-19 Vaccine Development Tools Market Share by Players (2018-2023)

    Table 18. Global Top COVID-19 Vaccine Development Tools Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in COVID-19 Vaccine Development Tools as of 2022)

    Table 19. Ranking of Global Top COVID-19 Vaccine Development Tools Companies by Revenue (US$ Million) in 2022

    Table 20. Global 5 Largest Players Market Share by COVID-19 Vaccine Development Tools Revenue (CR5 and HHI) & (2018-2023)

    Table 21. Key Players Headquarters and Area Served

    Table 22. Key Players COVID-19 Vaccine Development Tools Product Solution and Service

    Table 23. Date of Enter into COVID-19 Vaccine Development Tools Market

    Table 24. Mergers & Acquisitions, Expansion Plans

    Table 25. Global COVID-19 Vaccine Development Tools Market Size by Type (2018-2023) & (US$ Million)

    Table 26. Global COVID-19 Vaccine Development Tools Revenue Market Share by Type (2018-2023)

    Table 27. Global COVID-19 Vaccine Development Tools Forecasted Market Size by Type (2024-2029) & (US$ Million)

    Table 28. Global COVID-19 Vaccine Development Tools Revenue Market Share by Type (2024-2029)

    Table 29. Global COVID-19 Vaccine Development Tools Market Size by Application (2018-2023) & (US$ Million)

    Table 30. Global COVID-19 Vaccine Development Tools Revenue Market Share by Application (2018-2023)

    Table 31. Global COVID-19 Vaccine Development Tools Forecasted Market Size by Application (2024-2029) & (US$ Million)

    Table 32. Global COVID-19 Vaccine Development Tools Revenue Market Share by Application (2024-2029)

    Table 33. North America COVID-19 Vaccine Development Tools Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 34. North America COVID-19 Vaccine Development Tools Market Size by Country (2018-2023) & (US$ Million)

    Table 35. North America COVID-19 Vaccine Development Tools Market Size by Country (2024-2029) & (US$ Million)

    Table 36. Europe COVID-19 Vaccine Development Tools Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 37. Europe COVID-19 Vaccine Development Tools Market Size by Country (2018-2023) & (US$ Million)

    Table 38. Europe COVID-19 Vaccine Development Tools Market Size by Country (2024-2029) & (US$ Million)

    Table 39. Asia-Pacific COVID-19 Vaccine Development Tools Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 40. Asia-Pacific COVID-19 Vaccine Development Tools Market Size by Region (2018-2023) & (US$ Million)

    Table 41. Asia-Pacific COVID-19 Vaccine Development Tools Market Size by Region (2024-2029) & (US$ Million)

    Table 42. Latin America COVID-19 Vaccine Development Tools Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 43. Latin America COVID-19 Vaccine Development Tools Market Size by Country (2018-2023) & (US$ Million)

    Table 44. Latin America COVID-19 Vaccine Development Tools Market Size by Country (2024-2029) & (US$ Million)

    Table 45. Middle East & Africa COVID-19 Vaccine Development Tools Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 46. Middle East & Africa COVID-19 Vaccine Development Tools Market Size by Country (2018-2023) & (US$ Million)

    Table 47. Middle East & Africa COVID-19 Vaccine Development Tools Market Size by Country (2024-2029) & (US$ Million)

    Table 48. Thermo Fisher Scientific Company Detail

    Table 49. Thermo Fisher Scientific Business Overview

    Table 50. Thermo Fisher Scientific COVID-19 Vaccine Development Tools Product

    Table 51. Thermo Fisher Scientific Revenue in COVID-19 Vaccine Development Tools Business (2018-2023) & (US$ Million)

    Table 52. Thermo Fisher Scientific Recent Development

    Table 53. Pfizer Inc Company Detail

    Table 54. Pfizer Inc Business Overview

    Table 55. Pfizer Inc COVID-19 Vaccine Development Tools Product

    Table 56. Pfizer Inc Revenue in COVID-19 Vaccine Development Tools Business (2018-2023) & (US$ Million)

    Table 57. Pfizer Inc Recent Development

    Table 58. Celerion Company Detail

    Table 59. Celerion Business Overview

    Table 60. Celerion COVID-19 Vaccine Development Tools Product

    Table 61. Celerion Revenue in COVID-19 Vaccine Development Tools Business (2018-2023) & (US$ Million)

    Table 62. Celerion Recent Development

    Table 63. Cole-Parmer Instrument Company Company Detail

    Table 64. Cole-Parmer Instrument Company Business Overview

    Table 65. Cole-Parmer Instrument Company COVID-19 Vaccine Development Tools Product

    Table 66. Cole-Parmer Instrument Company Revenue in COVID-19 Vaccine Development Tools Business (2018-2023) & (US$ Million)

    Table 67. Cole-Parmer Instrument Company Recent Development

    Table 68. STEMCELL Technologies Company Detail

    Table 69. STEMCELL Technologies Business Overview

    Table 70. STEMCELL Technologies COVID-19 Vaccine Development Tools Product

    Table 71. STEMCELL Technologies Revenue in COVID-19 Vaccine Development Tools Business (2018-2023) & (US$ Million)

    Table 72. STEMCELL Technologies Recent Development

    Table 73. Illumina, Inc Company Detail

    Table 74. Illumina, Inc Business Overview

    Table 75. Illumina, Inc COVID-19 Vaccine Development Tools Product

    Table 76. Illumina, Inc Revenue in COVID-19 Vaccine Development Tools Business (2018-2023) & (US$ Million)

    Table 77. Illumina, Inc Recent Development

    Table 78. AB Sciex Private Limited Company Detail

    Table 79. AB Sciex Private Limited Business Overview

    Table 80. AB Sciex Private Limited COVID-19 Vaccine Development Tools Product

    Table 81. AB Sciex Private Limited Revenue in COVID-19 Vaccine Development Tools Business (2018-2023) & (US$ Million)

    Table 82. AB Sciex Private Limited Recent Development

    Table 83. Agilent Technologies Company Detail

    Table 84. Agilent Technologies Business Overview

    Table 85. Agilent Technologies COVID-19 Vaccine Development Tools Product

    Table 86. Agilent Technologies Revenue in COVID-19 Vaccine Development Tools Business (2018-2023) & (US$ Million)

    Table 87. Agilent Technologies Recent Development

    Table 88. Danaher Corporation Company Detail

    Table 89. Danaher Corporation Business Overview

    Table 90. Danaher Corporation COVID-19 Vaccine Development Tools Product

    Table 91. Danaher Corporation Revenue in COVID-19 Vaccine Development Tools Business (2018-2023) & (US$ Million)

    Table 92. Danaher Corporation Recent Development

    Table 93. Bio-Rad Laboratories Company Detail

    Table 94. Bio-Rad Laboratories Business Overview

    Table 95. Bio-Rad Laboratories COVID-19 Vaccine Development Tools Product

    Table 96. Bio-Rad Laboratories Revenue in COVID-19 Vaccine Development Tools Business (2018-2023) & (US$ Million)

    Table 97. Bio-Rad Laboratories Recent Development

    Table 98. Qiagen NV Company Detail

    Table 99. Qiagen NV Business Overview

    Table 100. Qiagen NV COVID-19 Vaccine Development Tools Product

    Table 101. Qiagen NV Revenue in COVID-19 Vaccine Development Tools Business (2018-2023) & (US$ Million)

    Table 102. Qiagen NV Recent Development

    Table 103. Merck KgaA Company Detail

    Table 104. Merck KgaA Business Overview

    Table 105. Merck KgaA COVID-19 Vaccine Development Tools Product

    Table 106. Merck KgaA Revenue in COVID-19 Vaccine Development Tools Business (2018-2023) & (US$ Million)

    Table 107. Merck KgaA Recent Development

    Table 108. Shimadzu Corporation Company Detail

    Table 109. Shimadzu Corporation Business Overview

    Table 110. Shimadzu Corporation COVID-19 Vaccine Development Tools Product

    Table 111. Shimadzu Corporation Revenue in COVID-19 Vaccine Development Tools Business (2018-2023) & (US$ Million)

    Table 112. Shimadzu Corporation Recent Development

    Table 113. PerkinElmer Inc Company Detail

    Table 114. PerkinElmer Inc Business Overview

    Table 115. PerkinElmer Inc COVID-19 Vaccine Development Tools Product

    Table 116. PerkinElmer Inc Revenue in COVID-19 Vaccine Development Tools Business (2018-2023) & (US$ Million)

    Table 117. PerkinElmer Inc Recent Development

    Table 118. Eurofins Scientific Company Detail

    Table 119. Eurofins Scientific Business Overview

    Table 120. Eurofins Scientific COVID-19 Vaccine Development Tools Product

    Table 121. Eurofins Scientific Revenue in COVID-19 Vaccine Development Tools Business (2018-2023) & (US$ Million)

    Table 122. Eurofins Scientific Recent Development

    Table 123. Aurora Biomed Company Detail

    Table 124. Aurora Biomed Business Overview

    Table 125. Aurora Biomed COVID-19 Vaccine Development Tools Product

    Table 126. Aurora Biomed Revenue in COVID-19 Vaccine Development Tools Business (2018-2023) & (US$ Million)

    Table 127. Aurora Biomed Recent Development

    Table 128. Sartorius AG Company Detail

    Table 129. Sartorius AG Business Overview

    Table 130. Sartorius AG COVID-19 Vaccine Development Tools Product

    Table 131. Sartorius AG Revenue in COVID-19 Vaccine Development Tools Business (2018-2023) & (US$ Million)

    Table 132. Sartorius AG Recent Development

    Table 133. Research Programs/Design for This Report

    Table 134. Key Data Information from Secondary Sources

    Table 135. Key Data Information from Primary Sources

List of Figures

    Figure 1. Global COVID-19 Vaccine Development Tools Market Size Comparison by Type (2023-2029) & (US$ Million)

    Figure 2. Global COVID-19 Vaccine Development Tools Market Share by Type: 2022 VS 2029

    Figure 3. Flow Cytometry Features

    Figure 4. Electron Microscopy Features

    Figure 5. Spectrometry Features

    Figure 6. Others Features

    Figure 7. Global COVID-19 Vaccine Development Tools Market Size Comparison by Application (2023-2029) & (US$ Million)

    Figure 8. Global COVID-19 Vaccine Development Tools Market Share by Application: 2022 VS 2029

    Figure 9. Pharmaceutical Company Case Studies

    Figure 10. Biotechnology Company Case Studies

    Figure 11. COVID-19 Vaccine Development Tools Report Years Considered

    Figure 12. Global COVID-19 Vaccine Development Tools Market Size (US$ Million), Year-over-Year: 2018-2029

    Figure 13. Global COVID-19 Vaccine Development Tools Market Size, (US$ Million), 2018 VS 2022 VS 2029

    Figure 14. Global COVID-19 Vaccine Development Tools Market Share by Region: 2022 VS 2029

    Figure 15. Global COVID-19 Vaccine Development Tools Market Share by Players in 2022

    Figure 16. Global Top COVID-19 Vaccine Development Tools Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in COVID-19 Vaccine Development Tools as of 2022)

    Figure 17. The Top 10 and 5 Players Market Share by COVID-19 Vaccine Development Tools Revenue in 2022

    Figure 18. North America COVID-19 Vaccine Development Tools Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 19. North America COVID-19 Vaccine Development Tools Market Share by Country (2018-2029)

    Figure 20. United States COVID-19 Vaccine Development Tools Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 21. Canada COVID-19 Vaccine Development Tools Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 22. Europe COVID-19 Vaccine Development Tools Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 23. Europe COVID-19 Vaccine Development Tools Market Share by Country (2018-2029)

    Figure 24. Germany COVID-19 Vaccine Development Tools Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 25. France COVID-19 Vaccine Development Tools Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 26. U.K. COVID-19 Vaccine Development Tools Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 27. Italy COVID-19 Vaccine Development Tools Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 28. Russia COVID-19 Vaccine Development Tools Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 29. Nordic Countries COVID-19 Vaccine Development Tools Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 30. Asia-Pacific COVID-19 Vaccine Development Tools Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 31. Asia-Pacific COVID-19 Vaccine Development Tools Market Share by Region (2018-2029)

    Figure 32. China COVID-19 Vaccine Development Tools Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 33. Japan COVID-19 Vaccine Development Tools Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 34. South Korea COVID-19 Vaccine Development Tools Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 35. Southeast Asia COVID-19 Vaccine Development Tools Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 36. India COVID-19 Vaccine Development Tools Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 37. Australia COVID-19 Vaccine Development Tools Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 38. Latin America COVID-19 Vaccine Development Tools Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 39. Latin America COVID-19 Vaccine Development Tools Market Share by Country (2018-2029)

    Figure 40. Mexico COVID-19 Vaccine Development Tools Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 41. Brazil COVID-19 Vaccine Development Tools Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 42. Middle East & Africa COVID-19 Vaccine Development Tools Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 43. Middle East & Africa COVID-19 Vaccine Development Tools Market Share by Country (2018-2029)

    Figure 44. Turkey COVID-19 Vaccine Development Tools Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 45. Saudi Arabia COVID-19 Vaccine Development Tools Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 46. Thermo Fisher Scientific Revenue Growth Rate in COVID-19 Vaccine Development Tools Business (2018-2023)

    Figure 47. Pfizer Inc Revenue Growth Rate in COVID-19 Vaccine Development Tools Business (2018-2023)

    Figure 48. Celerion Revenue Growth Rate in COVID-19 Vaccine Development Tools Business (2018-2023)

    Figure 49. Cole-Parmer Instrument Company Revenue Growth Rate in COVID-19 Vaccine Development Tools Business (2018-2023)

    Figure 50. STEMCELL Technologies Revenue Growth Rate in COVID-19 Vaccine Development Tools Business (2018-2023)

    Figure 51. Illumina, Inc Revenue Growth Rate in COVID-19 Vaccine Development Tools Business (2018-2023)

    Figure 52. AB Sciex Private Limited Revenue Growth Rate in COVID-19 Vaccine Development Tools Business (2018-2023)

    Figure 53. Agilent Technologies Revenue Growth Rate in COVID-19 Vaccine Development Tools Business (2018-2023)

    Figure 54. Danaher Corporation Revenue Growth Rate in COVID-19 Vaccine Development Tools Business (2018-2023)

    Figure 55. Bio-Rad Laboratories Revenue Growth Rate in COVID-19 Vaccine Development Tools Business (2018-2023)

    Figure 56. Qiagen NV Revenue Growth Rate in COVID-19 Vaccine Development Tools Business (2018-2023)

    Figure 57. Merck KgaA Revenue Growth Rate in COVID-19 Vaccine Development Tools Business (2018-2023)

    Figure 58. Shimadzu Corporation Revenue Growth Rate in COVID-19 Vaccine Development Tools Business (2018-2023)

    Figure 59. PerkinElmer Inc Revenue Growth Rate in COVID-19 Vaccine Development Tools Business (2018-2023)

    Figure 60. Eurofins Scientific Revenue Growth Rate in COVID-19 Vaccine Development Tools Business (2018-2023)

    Figure 61. Aurora Biomed Revenue Growth Rate in COVID-19 Vaccine Development Tools Business (2018-2023)

    Figure 62. Sartorius AG Revenue Growth Rate in COVID-19 Vaccine Development Tools Business (2018-2023)

    Figure 63. Bottom-up and Top-down Approaches for This Report

    Figure 64. Data Triangulation

    Figure 65. Key Executives Interviewed